We are live on ! Find out more
GA

General Atlantic Portfolio holdings

AUM $2.15B
1-Year Est. Return 35.02%
This Fund
S&P 500
This Quarter Est. Return
-4.94%
1 Year Est. Return
+35.02%
3 Year Est. Return
+185.68%
5 Year Est. Return
+122.28%
10 Year Est. Return
+1,080.07%
AUM
$4.31B
AUM Growth
-$2.67B
Cap. Flow
-$2.28B
Cap. Flow %
-53.06%
Top 10 Hldgs %
90.42%
Holding
26
New
Increased
3
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
AKRO
Akero Therapeutics
AKRO
+$82.8M
2
IMCR icon
Immunocore
IMCR
+$38.2M
3
PHVS icon
Pharvaris
PHVS
+$36.5M

Sector Composition

Rank Sector Weight
1 Technology 43.6%
2 Healthcare 22.69%
3 Financials 17.65%
4 Industrials 10.64%
5 Consumer Staples 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESMT
26
DELISTED
EngageSmart, Inc.
ESMT
-90,271,540
Closed -$2.07B

Similar funds

General Atlantic's Q1 2024 Portfolio in Review

As of Q1 2024, General Atlantic held 26 positions worth $4.31B, down 38% from $6.97B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

General Atlantic withdrew a net $2.28B in Q1 2024, closing 4 positions and reducing 1 holding. Its most notable exit was EngageSmart, Inc., an estimated $2.07B position sold in full.

By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 59% a quarter earlier, followed by Healthcare and Financials.

Against the trend, General Atlantic added an estimated $82.8M to Akero Therapeutics.

  • General Atlantic added most to Akero Therapeutics in Q1 2024, an estimated $82.8M increase.
  • General Atlantic's biggest Q1 2024 reduction was Mobileye, cutting an estimated $3.52M.
  • General Atlantic fully exited EngageSmart, Inc. in Q1 2024, selling an estimated $2.07B.
  • General Atlantic's ten largest holdings make up 90% of its $4.31B portfolio in Q1 2024.
  • General Atlantic opened 0 new positions and closed 4 in Q1 2024.
  • General Atlantic's portfolio value fell 38% quarter-over-quarter to $4.31B.

Based on General Atlantic's 13F filing for Q1 2024, filed 15 May 2024.